Outcomes from the International Survey Informing Greater Insights in Opioid Dependence Treatment (INSIGHT) project

References

• Ball, J.C., Lange, W.R., Myers, C.P., & Friedman, S.R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health & Social Behavior, 29, 214–226
   PubMed Web of Science ®Google Scholar
• Benyamina, A., & Stöver, H. (2012). Barriers to treatment access and informed patient choice in the treatment of opioid dependence in Europe. Heroin Addiction & Related Clinical Problems, 14, 65−80
   Web of Science ®Google Scholar
• Carrieri, M.P., Amass, L., Lucas, G.M., Vlahov, D., Wodak, A., & Woody, G.E. (2006). Buprenorphine use: The international experience. Clinical Infectious Diseases, 43, S197−S215
   PubMed Web of Science ®Google Scholar
• Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R.J., …Taylor, R.S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11, 1–71 (iii–iv)
   PubMed Web of Science ®Google Scholar
• Dale-Perera, A., Goulão, J., & Stöver, H. (2012). Quality of care provided to patients receiving opioid maintenance treatment in Europe: Results from the EQUATOR. Heroin Addiction & Related Clinical Problems, 14, 23–38
   Web of Science ®Google Scholar
• Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet, 379, 55–70
   PubMed Web of Science ®Google Scholar
• Department of Health (England) and the devolved administrations. (2007). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive. Available at: http://www.nta.nhs.uk/uploads/clinical_guidelines_2007.pdf
   Google Scholar
• Doran, C., Holmes, J., Ladewig, D., & Ling, W. (2005). Buprenorphine induction and stabilisation in the treatment of opiate dependence. Heroin Addiction & Related Clinical Problems, 7, 7–18
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2010). Harm reduction: Evidence, impacts and challenges. EMCDDA Scientific Monograph Series No.10, Luxembourg: Publications Office of the European Union. Available at: http://www.emcdda.europa.eu/publications/monographs/harm-reduction
   Google Scholar
• Fischer, B., Chin, A.T., Kuo, I., Kirst, M., & Vlahov, D. (2002). Canadian illicit opiate users' views on methadone and other opiate prescription treatment: An exploratory qualitative study. Substance Use & Misuse, 37, 495–522
   PubMed Web of Science ®Google Scholar
• Fischer, G., Nava, F., & Stöver, H. (2012). Outcomes of opioid-dependence treatment across Europe: Identifying opportunities for improvement. Heroin Addiction & Related Clinical Problems, 14, 39–50
   Google Scholar
• Fischer, G., & Stöver, H. (2012). Assessing the current state of opioid-dependence treatment across Europe: Methodology of the European Quality Audit of Opioid Treatment (EQUATOR) project. Heroin Addiction & Related Clinical Problems, 14, 5–70
   Web of Science ®Google Scholar
• Ford, C., Halliday, K., Lawson, E., & Browne, E. (2011). Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care. London: Royal College of General Practitioners. Available at: www.smmgp.org.uk/download/guidance/guidance004.pdf
   Google Scholar
• Fudala, P.J., Bridge, T.P., Herbert, S., Williford, W.O., Chiang, C.N., Jones, K., …. Buprenorphine/Naloxone Collaborative Study Group. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349, 949–958
   PubMed Web of Science ®Google Scholar
• Goulão, J., & Stöver, H. (2012). The profile of patients, out-of-treatment users and treating physicians involved in opioid maintenance treatment in Europe. Heroin Addiction & Related Clinical Problems, 14, 7–22
   Web of Science ®Google Scholar
• Hyman, S.E., & Malenka, R.C. (2001). Addiction and the brain: The neurobiology of compulsion and its persistence. Nature Reviews Neuroscience, 2, 695–703
   PubMed Web of Science ®Google Scholar
• Kayman, D.J., Goldstein, M.F., Deren, S., & Rosenblum, A. (2006). Predicting treatment retention with a brief “Opinions About Methadone” scale. Journal of Psychoactive Drugs, 38, 93–100
   PubMed Web of Science ®Google Scholar
• Lawrinson, P., Ali, R., Buavirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., … Zhao, C. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103, 1484–1492
   PubMed Web of Science ®Google Scholar
• Leshner, A.I. (1997). Addiction is a brain disease, and it matters. Science, 278, 45–47
   PubMed Web of Science ®Google Scholar
• Madden, A., Lea, T., Bath, N., & Winstock, A.R. (2008). Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug & Alcohol Review, 27, 671–678
   PubMed Web of Science ®Google Scholar
• Mitchell, T.B., White, J.M., Somogyi, A.A., & Bochner, F. (2003). Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug & Alcohol Dependence, 72, 85–94
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA), National Institute of Health (NIH). (2009). Principles of drug addiction treatment: A research-based guide (3rd ed.). NIH Publication No. 12-4180. Washington, DC: US Department of Health and Human Services. Available at: http://www.drugabuse.gov/sites/default/files/podat_1.pdf
   Google Scholar
• National Treatment Agency for Substance Misuse (NTA). (2012). Drug treatment 2012: Progress made, challenges ahead. UK: National Health Service UK. Available at: www.nta.nhs.uk/uploads/commentaryfinal[0].pdf
   Google Scholar
• O'Brien, C.P., & McLellan, A.T. (1996). Myths about the treatment of addiction. Lancet, 347, 237–240
   PubMed Web of Science ®Google Scholar
• Pinto, H., Rumball, D., & Holland, R. (2008). Attitudes and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy. Journal of Substance Use, 13, 143–153
   Web of Science ®Google Scholar
• Stöver, H. (2011). Barriers to opioid substitution treatment access, entry and retention: A survey of opioid users, patients in treatment, and treating and non-treating physicians. European Addiction Research, 17, 44–54
   PubMed Web of Science ®Google Scholar
• Stöver, H. (2012). Assessing the current state of public-health-related outcomes in opioid dependence across Europe: Data from the EQUATOR analysis. Heroin Addiction & Related Clinical Problems, 14, 51–64
   Web of Science ®Google Scholar
• World Health Organization (WHO). (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: WHO Press. Available at: www.who.int/substance_abuse/publications/treatment/en/index.html
   Google Scholar
• World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), & Joint United Nations Program on HIV/AIDS (UNAIDS). (2004). WHO/UNODC/UNAIDS Position Paper: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: Publications of the World Health Organization. Available at: http://www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf
   Google Scholar